The Trump administration's budget proposal for 2026 looks to make cuts to HIV prevention in clinics and community ...

Drugmaker Gilead Sciences is not only providing the shot in the US, but is also working with governments and health groups in the UK and low-income countries to make these products more available.

HIV cases in the Philippines continue to rise, prompting health authorities to recommend declaring a public health emergency.

Updated CDC guidelines on PEP after nonoccupational HIV exposure address newer ART agents and clinical considerations for patients with a history of long-acting ART.

(Reuters) -Gilead Sciences says it still plans to supply its twice-yearly injection for preventing HIV infection in ...

The Trump administration is planning to eliminate the Centers for Disease Control and Prevention’s Division of HIV Prevention. The collapse of HIV prevention will mean 143,000 additional people in the ...

In February 2024, the U.S. Department of Health and Human Services Panel for the Use of Antiretroviral Agents in Adults and ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

A population-based study finds that nearly 15% of individuals using HIV preexposure prophylaxis are diagnosed with alcohol ...